市场调查报告书
商品编码
1408987
全球极外侧椎间融合 (XLIF) 手术市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
全球极外侧椎间融合术 (XLIF) 手术市场的需求预计将从 2022 年的 10 亿美元增至 2030 年的近 15.9 亿美元,2023 年至 2030 年的研究期间CAGR为 5.89%。
极外侧椎间融合术 (XLIF) 是一种透过从侧面进入脊椎(外侧入路)来治疗某些脊椎疾病的外科手术。这种微创技术使外科医生能够解决退化性椎间盘疾病、椎间盘突出或脊椎不稳定等问题,而无需采用传统的后路或前路方法。
对微创脊椎手术的需求和脊椎手术技术的进步推动了极外侧椎间融合手术市场的发展。该手术是传统脊椎手术的一种侵入性较小的替代方案,因其潜在的好处而受到患者的青睐,包括缩短恢復时间和减少术后疼痛。全球人口老化导致脊椎退化性疾病的发生率不断增加,推动了对 XLIF 手术的需求。手术技术和影像技术的不断进步以及外科医生的采用,提高了手术的精确度和安全性。患者对微创手术的偏好与 XLIF 手术一致,进一步提高了其受欢迎程度。有利的报销政策、积极的临床结果以及支持 XLIF 疗效的证据有助于其在医学界的接受。
研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具还对全球极端侧向椎间融合 (xlif) 手术市场的各个细分市场进行了包容性评估。极端侧向椎间融合 (xlif) 手术产业的成长和趋势为这项研究提供了整体方法。
本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲的极外侧椎间融合 (XLIF) 手术市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。
该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。极外侧椎间融合(XLIF) 手术市场的主要参与者包括美敦力公司(Medtronic plc)、强生公司(Johnson & Johnson)、史赛克公司(Stryker Corporation)、Zimmer Biomet Holdings Inc.、NuVasive Inc.、Globus Medical Inc.、DePuy Synthes、B. Braun Melsungen AG、Alphatec Holdings Inc.、RTI Surgical Holdings Inc.、K2M Group Holdings Inc.、Orthofix Medical Inc.、Aesculap Implant Systems、SpineWave Inc.、MicroPort Scientific Corporation、Life Spine Inc .、Captiva Spine Inc.。竞争格局,包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。
如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。
The global demand for Extreme Lateral Interbody Fusion (XLIF) Surgery Market is presumed to reach the market size of nearly USD 1.59 BN by 2030 from USD 1 BN in 2022 with a CAGR of 5.89% under the study period 2023 - 2030.
Extreme Lateral Interbody Fusion (XLIF) is a surgical procedure used to treat certain spinal conditions by accessing the spine from the side (lateral approach). This minimally invasive technique allows surgeons to address issues such as degenerative disc disease, disc herniation, or instability of the spine without the need for traditional posterior or anterior approaches.
The extreme lateral interbody fusion surgery market is fueled by the demand for minimally invasive spinal procedures and advancements in spinal surgery techniques. Offering a less invasive alternative to traditional spinal surgeries, this procedure is preferred by patients for its potential benefits, including shorter recovery times and reduced postoperative pain. The aging global population contributes to the increasing incidence of degenerative spinal conditions, driving the demand for XLIF procedures. Ongoing technological advancements in surgical technologies and imaging, along with its adoption by surgeons, enhance the precision and safety of the procedure. Patient preferences for minimally invasive options align with XLIF surgery, further boosting its popularity. Favorable reimbursement policies, positive clinical outcomes, and evidence supporting XLIF's efficacy contribute to its acceptance within the medical community.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of extreme lateral interbody fusion (xlif) surgery. The growth and trends of extreme lateral interbody fusion (xlif) surgery industry provide a holistic approach to this study.
This section of the extreme lateral interbody fusion (xlif) surgery market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Extreme Lateral Interbody Fusion (XLIF) Surgery market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Extreme Lateral Interbody Fusion (XLIF) Surgery market include Medtronic plc, Johnson & Johnson, Stryker Corporation, Zimmer Biomet Holdings Inc., NuVasive Inc., Globus Medical Inc., DePuy Synthes, B. Braun Melsungen AG, Alphatec Holdings Inc., RTI Surgical Holdings Inc., K2M Group Holdings Inc., Orthofix Medical Inc., Aesculap Implant Systems, SpineWave Inc., MicroPort Scientific Corporation, Life Spine Inc., Captiva Spine Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.